Our Team

Before forming Apogenics, he was Vice President of Payer Contracting at US BioServices, a division of AmerisourceBergen (NYSE:ABC). In this senior management role, he was responsible for all aspects of payer related contracting including application and maintenance of professional and drug wholesale licensure for 9 specialty pharmacy operations. He executed contracts with over 100 major payers (United Healthcare, Aetna, Kaiser, Blue Cross, Humana, et cetera) nationwide for specialty pharmacy or ancillary services. Prior to his work in the specialty pharmacy markets, Dr. Strollo was Chief Pharmacy Officers for Independence Blue Cross, an independent licensee of the Blue Cross and Blue Shield Association. This included services lines including Managed Care, Traditional Indemnity, Medicare and Medicaid. As Chief Pharmacy Officer his responsibilities included all aspects of pharmacy benefits management for over 4 million members with a $1.5B drug budget and over 19 million prescription drug claims. He managed a staff of 45 and a budget of $2.5 M. He was one of the first to implement the e-Pocrates platform for internet-based formularies. He contracted with over 50,000 vendors to provide national retail, mail, and specialty pharmacy network options. He developed the first high cost injectable and infusion drug program with preferred discounts leading to over $10M in savings. Prior to leading Independence Blue Cross, Dr. Strollo was Pharmacy Director at His/Qual-Med Plans for Health where he managed over 100,000 lives in all lines of business. Dr. Strollo led The State of New Jersey’s Drug Utilization Review Council under Governor Thomas Kean.

Dr. Strollo is a graduate of Howard University’s Doctor of Pharmacy program, in addition to receiving his master’s in finance from Drexel University. He is a distinguished graduate of the Philadelphia College of Pharmacy and Science where he earned his Bachelor of Pharmacy.